Glucose Sensors Market Report

Diabetes impacts people of every age, gender, and location, making it a leading worldwide cause of death and illness. About 422 million people around the world have diabetes, with most living in low- and middle-income countries. Types 1 and 2 are the most prevalent forms of DM, each with established diagnostic criteria. An autoimmune response is believed to be the cause of type 1 diabetes when the body mistakenly attacks itself. This process damages the pancreatic cells responsible for producing insulin, which are known as beta cells. The process may continue for months or years before any symptoms become noticeable. Socio-economic, demographic, environmental, and genetic factors drive 96% of type 2 diabetes (T2D) cases worldwide.

The main risk factor for type 2 diabetes is having a high BMI of 30.0 or above, which accounts for 52.2% of disability and mortality associated with the disease. The illness causes 1.5 million deaths each year. Dietary risks were followed by environmental/occupational, tobacco, physical inactivity, and alcohol risks. Approximately 1.28 billion adults worldwide aged 30-79 are facing hypertension, while more than 300 million people are currently dealing with the disease, leading to an increased demand for daily disease management by patients. Considering the age of patients aged 45–65 is crucial when seeking their viewpoints on self-management or treatments. The growing worldwide occurrence of diabetes and the increasing need for disease management drive the market.

Furthermore, traditional fingerstick tests provide a snapshot of blood glucose at a single point in time, and wearable sensors continuously monitor glucose levels & allow for more frequent and detailed data collection. Effective diabetes management involves maintaining blood glucose levels within a healthy sugar level of less than 140 mg/dL (7.8 mmol/L) is normal to prevent complications, which can include cardiovascular disease, kidney failure, neuropathy, and blindness.

Wearable glucose sensors can enhance the quality of life for individuals with diabetes by minimizing the necessity of frequent fingerstick tests and offering continuous monitoring, leading to more convenience and precise management of their condition. Wearable sensors have the capability to be set up to notify individuals if glucose levels are either too high or too low. This characteristic is essential in order to avoid severe episodes of hypoglycemia or hyperglycemia. easy-to-use insulin administration tools and wearable devices for monitoring glucose levels drives the market.

Balancing glycosylated haemoglobin HbA1c goals with reducing hypoglycaemia is a constant struggle for insulin-treated diabetes patients. Yet, with advancements in technology like continuous glucose monitoring (CGM), connected insulin pens (CIPs), insulin pumps, and automated insulin delivery (AID) algorithms, along with education, sensor accuracy, wear time (7–14 days, depending on the sensor), and size of CGM devices continue to improve, their usage is rapidly increasing. And offers unique characteristics, like methods for monitoring diet, exercise habits, and medication intake; the capacity to transfer information to a computer or smart device in order to conveniently monitor patterns in blood sugar level; a warning signal that activates if blood sugar is too low or too high; assisting in avoiding critical situations.

For instance, connecting CGM systems with mobile apps such as the Dexcom G7 CGM System is available for people with type 1 or type 2 diabetes. The Dexcom G7 is made to be more compact and inconspicuous than older versions, allowing for more comfortable continuous wear by users. Moreover, there is a shift towards the creation of new technologies and the introduction of products with advanced features by medical device manufacturers, leading to market expansion. Sensors offer convenient glucose monitoring for people of all ages, providing better support. Continuous glucose monitoring features in sensors are especially helpful for children and adolescents with varying eating habits, activity levels, and insulin needs. CGM systems lessen the requirement for regular fingerstick tests, which can be especially difficult for younger people, and allow for convenient monitoring of glucose levels and sharing of data with healthcare providers for improved management.

For adults, continuous glucose monitoring aids in making informed choices about insulin dosage, diet, and physical activity, resulting in better diabetes control. Pregnant women with diabetes, whether expecting or planning to conceive, can benefit from CGM systems' vital insights into glucose control for the well-being of both mother and baby. Elderly individuals, who may struggle with manual fingerstick tests, can also benefit from CGM systems that offer continuous monitoring without frequent blood samples. Systems aid elderly individuals in controlling their diabetes by providing ongoing information on glucose levels. They assist in avoiding immediate (e.g., hypoglycaemia) and lasting complications (e.g., cardiovascular disease, kidney disease) linked to diabetes.

• Rising incidences of diabetes and early detection and intervention of chronic diseases
• Continuous glucose monitoring for real-time data collection
• Wearable devices such as continuous glucose monitoring sensors helping in diabetes management with fewer fingerstick checks.
• More investment by governments in developing new technologies in diabetic care
• Focus on user-friendly devices and less or minimum invasive procedures

Glucose sensors utilize advanced technology to continuously monitor glucose levels and transmit data to a receiver or smartphone. Significant costs are linked to the research, development, and manufacturing involved in the making of these technologies. Although glucose sensors offer continuous data, unlike traditional blood glucose meters that only require occasional testing, this leads to increased costs due to the need for more advanced components and sensors. Sensors must have the ability to endure ongoing usage, such as exposure to bodily fluids and movement, without being easily damaged. Ensuring their cost is increased by ensuring reliability and accuracy throughout their lifespan.

Regulatory standards must be met by glucose sensors to guarantee safety, accuracy, and effectiveness. Adhering to these regulations requires spending more money on testing, certification, and continuous quality control. Expenses for Research and Development: The creation of new sensor technologies and enhancements to current ones necessitate significant investments in research, clinical testing, and regulatory authorizations, which are ultimately reflected in the cost of the end product. Accuracy and reliability of glucose sensors mainly affect the effectiveness of diabetes management.

The accuracy of the sensor is influenced by the type of sensing technology such as enzymatic or electrochemical and the specific method utilized for measuring glucose like amperometry or potentiometric. Interference refers to substances or conditions including medications, temperature changes, and pH variations that can disrupt sensor readings and impact accuracy. Certain sensors need regular adjustment through traditional fingerstick tests to guarantee accuracy. The overall accuracy can be influenced by how often calibration is conducted and the method used.

The growing number of diabetes cases is leading to a higher demand for more precise and accurate methods of diagnosis and prevention. Consistently tracking blood sugar levels is a crucial part of managing diabetes. For instance, in June 2024, Abbott received approval from the FDA for two new over-the-counter continuous glucose monitoring systems namely, Lingo and Libre Rio, utilizing Abbott's Freestyle Libre technology, which is meant for individuals who are 18 years and older and aims to enhance their general health and well-being. Lingo monitors sugar levels and offers individualized guidance and tailored coaching to assist individuals in forming healthy habits, resetting their metabolism, and enhancing their overall health. Libre Rio is the initial CGM system available without a prescription, which can measure glucose levels as low as 40 mg/dL and as high as 400 mg/dL.

Furthermore, Medtronic made an announcement in January 2024 that certification of the CE (Conformité Européenne) mark has been given to the MiniMed 780G system with Simplera Sync, which includes an all-in-one continuous glucose monitor (CGM) that is disposable and does not need fingerstick or overtape. Medtronic's most advanced insulin delivery system, the MiniMed 780G, automatically corrects glucose levels every 5 minutes and uniquely offers a Meal Detection feature to help manage post-meal hyperglycemia for users who may forget to dose insulin accurately. Such type of pioneering solution with well-integrated systems by key players uplifts the market growth.

The rising occurrence of diabetes and other chronic diseases like hypertension and asthma in North America drives the market growth. As per the Centre for Disease Control and Prevention, 1 in 3 adults have been identified as having prediabetes, with over 37 million Americans affected. According to WHO, the cases of hypertension is about 1.28 billion adults globally between the ages of 30 and 79 and over 300 million individuals are suffering from it, the need for patients to manage their diseases on a daily basis has increased. The American Diabetes Association approximates that 1.4 million Americans choose to undergo diabetes screening annually. Due to high administrative costs and utilizing cutting-edge medical technology, advanced treatments enhance patient results and care quality. However, these treatments come with expensive costs related to research, development, and implementation.

dditionally, the market is being influenced by the increasing demand for insulin delivery devices that are easy for users to use. During the forecast period, market growth is anticipated to be driven by technological advancements in the area. New developments and devices with innovative features by the United States key players boost the glucose sensor market in North America. For instance, in June 2024, Abbott received approval from FDA for two new over-the-counter continuous glucose monitoring systems: Lingo and Libre Rio, utilizing Abbott's Freestyle Libre technology. Libre Rio is Abbott's initial CGM system available without a prescription for adults in the U.S. people with Type 2 diabetes who do not require insulin and typically handle their diabetes with lifestyle changes. Libre Rio is the first CGM system available without a prescription, with a measurement range from 40 to 400 mg/dL, enabling the detection of very low or high glucose levels. Therefore, owing to the factors mentioned above drive the glucose sensors market in North America.

The report provides a detailed overview of the Glucose sensors market insights in regions including North America, Latin America, Europe, Asia-Pacific, Oceania, and the Middle East and Africa. The country-specific assessment for Glucose sensors market has been offered for all regional market share, along with forecasts, market scope estimates, price point assessment, and impact analysis of prominent countries and regions. Throughout this market research report, Y-o-Y growth and CAGR estimates are also incorporated for every country and region, to provide a detailed view of the Glucose sensors market. These Y-o-Y projections on regional and country-level markets brighten the political, economic and business environment outlook, which are anticipated to have a substantial impact on the growth of the Glucose sensors market. Some key country and region included in the Glucose sensors market report as follows:

• Glucose sensors market detailed segments and segment-wise market breakdown
• Glucose sensors market dynamics (Recent industry trends, drivers, restraints, growth potential, opportunities in Glucose sensors industry)
• Current, historical and forthcoming 10 years market valuation in terms of Glucose sensors market size (US$ Mn), volume (Units), share (%), Y-o-Y growth rate, CAGR (%) analysis
• Glucose sensors market demand analysis
• Glucose sensors market pricing analysis over forecast period (by key segment and by region)
• Glucose sensors market regional insights with region-wise market breakdown
• Competitive analysis – key companies profiling including their market share, product offerings, and competitive strategies.
• Latest developments and innovations in Glucose sensors market
• Regulatory landscape by key regions and key countries
• Supply chain and value chain analysis in Glucose sensors market
• Glucose sensors market sales and distribution strategies
• A comprehensive overview of parent market
• A detailed viewpoint on Glucose sensors market forecast by countries
• Mergers and acquisitions in Glucose sensors market
• Essential information to enhance market position
• Robust research methodology